EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Growth-associated protein 43 is associated with faster functional decline among amyloid-positive individuals with objectively defined subtle cognitive decline and mild cognitive impairment.

Amanda I Gonzalez, Lauren C Edwards, Kelsey R Thomas, Alexandra J Weigand, Maria Bordyug, Einat K Brenner, Uriel A Urias, Katherine J Bangen iD

Neuropsychology · 2025

DOI: 10.1037/neu0000981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychology, 2025. Verfasst von Amanda I Gonzalez und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of California San Diego, Department of Psychiatry. Hauptthemen laut MEDLINE: Cognitive Dysfunction, GAP-43 Protein, Amyloid beta-Peptides, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CSRD VA, NIA NIH HHS, Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionGAP-43 ProteinAmyloid beta-PeptidesAlzheimer DiseaseHumansMaleFemaleAgedBiomarkersDisease ProgressionCross-Sectional StudiesAged, 80 and over

Substanzen

GAP-43 ProteinBiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • University of California San Diego, Department of Psychiatry.
  • San Diego State University, Department of Psychology.

ORCID-Profile: Katherine J Bangen

Förderung

  • CSRD VA
  • NIA NIH HHS
  • Alzheimer's Association
  • NIH HHS
  • Department of Defense
  • U.S. Department of Veterans Affairs Clinical Sciences Research and Development Service
  • National Institutes of Health
  • Alzheimer’s Association

Zitieren

APA

Gonzalez, A. I., Edwards, L. C., Thomas, K. R., Weigand, A. J., Bordyug, M., Brenner, E. K., Urias, U. A., & Bangen, K. J. (2025). Growth-associated protein 43 is associated with faster functional decline among amyloid-positive individuals with objectively defined subtle cognitive decline and mild cognitive impairment. Neuropsychology. https://doi.org/10.1037/neu0000981

Vancouver

Gonzalez AI, Edwards LC, Thomas KR, Weigand AJ, Bordyug M, Brenner EK, et al. Growth-associated protein 43 is associated with faster functional decline among amyloid-positive individuals with objectively defined subtle cognitive decline and mild cognitive impairment. Neuropsychology. 2025. doi:10.1037/neu0000981

BibTeX
@article{Gonzalez2025,
  author = {Gonzalez, Amanda I and Edwards, Lauren C and Thomas, Kelsey R and Weigand, Alexandra J and Bordyug, Maria and Brenner, Einat K and Urias, Uriel A and Bangen, Katherine J},
  title = {Growth-associated protein 43 is associated with faster functional decline among amyloid-positive individuals with objectively defined subtle cognitive decline and mild cognitive impairment},
  journal = {Neuropsychology},
  year = {2025},
  doi = {10.1037/neu0000981}
}
Kostenlos starten →